首页> 外文期刊>South African medical journal = >Management of asthma exacerbations in children
【24h】

Management of asthma exacerbations in children

机译:哮喘治疗儿童哮喘加剧

获取原文
       

摘要

Asthma exacerbations are episodes of worsening asthma symptoms with shortness of breath, cough, wheeze and/or tight chest that require an increase in asthma treatment. A major change in the recommendations for managing mild asthma exacerbations is the move away from using inhaled short-acting beta-2 agonists (SABAs) as the sole reliever, toward a combination of a rapid-onset, long-acting beta-2 agonist, formoterol, in combination with an inhaled corticosteroid (ICS), or a SABA used together with an ICS in separate inhalers, in older children and adolescents. In children 11 years of age who are adherent to daily ICS treatment, the ICS dose should not be increased short term. A written asthma plan should include instructions on how to self-manage asthma exacerbations, and when to present to a medical facility. Oxygen is an essential component of the management of asthma exacerbations at both primary care and emergency department facilities, together with inhaled SABAs via metered-dose inhaler and spacer, and oral corticosteroids.
机译:哮喘恶化是一种恶化哮喘症状,呼吸急促,咳嗽,喘息和/或紧胸部需要增加哮喘治疗。管理轻度哮喘的建议的主要变化是远离使用吸入的短作用β-2激动剂(SABAS)作为唯一的缓解,朝着快速发作,长效β-2激动剂的组合, Formoterol与吸入的皮质类固醇(IC)组合,或者与旧的儿童和青少年分开吸入器中的IC一起使用的SABA。在儿童& 11岁的人依赖日常ics治疗,ICS剂量不应增加短期。书面哮喘计划应包括有关如何自我管理哮喘恶化的说明,以及何时展示给医疗机构。氧气是在初级保健和急诊部门设施的哮喘加剧管理的重要组成部分,通过计量剂量吸入器和间隔和口腔皮质类固醇以及吸入的SABA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号